Coloplast Corp.

Coloplast A/S is a Denmark-based multinational manufacturer of intimate healthcare solutions serving 2 million+ patients across 100+ countries. The company specializes in six primary care areas: Ostomy Care (pouching systems and related products for colostomy, ileostomy, and urostomy patients); Continence Care (intermittent catheters and urinary collection devices); Interventional Urology (implants, surgical slings, and urology instruments); Bowel Care (transanal irrigation systems for bowel management); Wound & Tissue Repair (advanced wound dressings and biologic products); and Voice and Respiratory Care (voice prostheses, heat and moisture exchangers, tracheostomy tubes, and adhesives). Coloplast manufactures and distributes medical devices and consumables directly and through distributors in markets where subsidiaries are not established. The company operates customer care centers globally and provides comprehensive support services through Coloplast Care (patient support and education) and Coloplast Professional (healthcare provider training and clinical resources). Products are designed with user-centered innovation informed by patient feedback. The company maintains regulatory compliance across major markets and serves hospitals, clinics, home care settings, and individual patients. Coloplast is publicly listed on the Copenhagen Stock Exchange (ticker: COLO B).